Odyssey Therapeutics Inc. (ODTX:NASDAQ) closed at $18.10 on October 19, 2026, up 5.42% on the day. The stock trades 37.7% below its 52-week high of $29.05 and 19.9% above its 52-week low of $15.10. Over the past year, it gained 10.2%. Odyssey Therapeutics Inc. is part of the Health Care sector.
In 112 trading sessions since May 11, 2026, ODTX closed higher on 58 days (52%). Its best day was August 19, 2026 (+10.48%) and its worst was October 6, 2026 (-13.00%). The stock moved 10% or more in a single session 5 times.
Odyssey Therapeutics is a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases by developing medicines that are designed to precisely target disease pathology. Since its founding in 2021, Odyssey has built a portfolio of completely internally discovered and developed medicines with its first program advancing through multiple clinical milestones. The portfolio leverages the scientific expertise of its team of experienced drug hunters and a comprehensive suite of tools to efficiently advance product candidates that the company believe have the potential to induce deep and durable remission for patients across several inflammatory diseases with unmet need.
Find more stocks like ODTX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.